EUVIMEDEUVIMED entdecken
Open Access

Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor–induced immune responses

Megan Cole iD, Panayiotis Anastasiou, Claudia Lee iD, Xiaofei Yu iD, Andrea de Castro iD, Jannes Roelink, Chris Moore iD, Edurne Mugarza iD, Martin Jones iD, Karishma Valand iD, Sareena Rana iD, Emma Colliver iD und 10 weitere

Science Advances · 2024-11 · 10 (44)

DOI: 10.1126/sciadv.adl6464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024-11. Verfasst von Megan Cole und 21 weiteren Autor:innen. Beteiligte Einrichtung: Oncogene Biology Laboratory, Francis Crick Institute, London, UK. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Lung Neoplasms, Proto-Oncogene Proteins p21(ras), Tumor Microenvironment. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kirsten rat sarcoma virus (KRAS)–G12C inhibition causes remodeling of the lung tumor immune microenvironment and synergistic responses to anti–PD-1 treatment, but only in T cell infiltrated tumors. To investigate mechanisms that restrain combination immunotherapy sensitivity in immune-excluded tumors, we used imaging mass cytometry to explore cellular distribution in an immune-evasive KRAS mutant lung cancer model. Cellular spatial pattern characterization revealed a community where CD4 + and CD8 + T cells and dendritic cells were gathered, suggesting localized T cell activation. KRAS-G12C inhibition led to increased PD-1 expression, proliferation, and cytotoxicity of CD8 + T cells, and CXCL9 expression by dendritic cells, indicating an effector response. However, suppressive regulatory T cells (T regs ) were also found in frequent contact with effector T cells within this community. Lung adenocarcinoma clinical samples showed similar communities. Depleting T regs led to enhanced tumor control in combination with anti–PD-1 and KRAS-G12C inhibitor. Combining T reg depletion with KRAS inhibition shows therapeutic potential for increasing antitumoral immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryLung NeoplasmsProto-Oncogene Proteins p21(ras)Tumor MicroenvironmentAnimalsHumansMiceCD8-Positive T-LymphocytesCell Line, TumorProgrammed Cell Death 1 ReceptorMutationImmunotherapyDendritic Cells

Substanzen

Proto-Oncogene Proteins p21(ras)Programmed Cell Death 1 ReceptorKRAS protein, humanHras protein, mouse

Autor:innen und Institutionen

  • Oncogene Biology Laboratory, Francis Crick Institute, London, UK.
  • Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, UK.
  • Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands.
  • Electron Microscopy, Francis Crick Institute, London, UK.

ORCID-Profile: Megan Cole, Claudia Lee, Xiaofei Yu, Andrea de Castro, Chris Moore, Edurne Mugarza, Martin Jones, Karishma Valand, Sareena Rana, Emma Colliver, Mihaela Angelova, Katey S S Enfield, Alastair Magness, Asher Mullokandov, Gavin Kelly, Miriam Molina-Arcas, Charles Swanton, Julian Downward, Febe van Maldegem

Förderung

  • Wellcome Trust

Zitieren

APA

Cole, M., Anastasiou, P., Lee, C., Yu, X., de Castro, A., Roelink, J., Moore, C., Mugarza, E., Jones, M., Valand, K., Rana, S., Colliver, E., Angelova, M., Enfield, K. S. S., Magness, A., Mullokandov, A., Kelly, G., de Gruijl, T. D., Molina-Arcas, M., …, & van Maldegem, F. (2024). Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor–induced immune responses. Science Advances, 10(44). https://doi.org/10.1126/sciadv.adl6464

Vancouver

Cole M, Anastasiou P, Lee C, Yu X, de Castro A, Roelink J, et al. Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor–induced immune responses. Science Advances. 2024;10(44). doi:10.1126/sciadv.adl6464

BibTeX
@article{Cole2024,
  author = {Cole, Megan and Anastasiou, Panayiotis and Lee, Claudia and Yu, Xiaofei and de Castro, Andrea and Roelink, Jannes and Moore, Chris and Mugarza, Edurne and Jones, Martin and Valand, Karishma and Rana, Sareena and Colliver, Emma and Angelova, Mihaela and Enfield, Katey S S and Magness, Alastair and Mullokandov, Asher and Kelly, Gavin and de Gruijl, Tanja D and Molina-Arcas, Miriam and Swanton, Charles and Downward, Julian and van Maldegem, Febe},
  title = {Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor–induced immune responses},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {44},
  doi = {10.1126/sciadv.adl6464}
}
Kostenlos starten →